| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $83.3M | +4.8% |
| Cost of Revenue | $55.0M | +13.6% |
| R&D Expense | $76.0M | +10.4% |
| SG&A Expense | $62.9M | +2.1% |
| Operating Income | -$130.7M | -10.6% |
| Pre-tax Income | -$88.8M | +39.3% |
| Income Tax | -$342K | +33.8% |
| Net Income | -$84.6M | +41.8% |
| EPS (Basic) | -$0.46 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $86.7M | -43.2% |
| Accounts Receivable | $14.0M | -45.9% |
| Inventory | $15.5M | -33.2% |
| Current Assets | $120.3M | -42.3% |
| Total Assets | $390.0M | -19.7% |
| Current Liabilities | $21.1M | -58.0% |
| Total Liabilities | $42.0M | -60.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.8M | -46.7% |
| Capital Expenditures | $6.8M | +41.6% |
| Investing Cash Flow | -$9.3M | -60.3% |
| Financing Cash Flow | $3.5M | -96.0% |
| Free Cash Flow | -$65.6M | -46.2% |
| +46.5% |
| EPS (Diluted) | -$0.46 | +46.5% |
| Stockholders' Equity |
| $348.0M |
| -8.6% |